GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials

The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released from enteroendocrine cells in response to the presence of nutrients in the small intestines. These homones facilitate glucose regulation by stimulating insulin secretion in a glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Matthew P., Pratley, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145895/
https://www.ncbi.nlm.nih.gov/pubmed/32308645
http://dx.doi.org/10.3389/fendo.2020.00178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145895/
https://www.ncbi.nlm.nih.gov/pubmed/32308645
http://dx.doi.org/10.3389/fendo.2020.00178

Ejemplares similares